Region: United Kingdom

Supreme Court appeal and legislation possible after latest UK DABUS patent decision

The England and Wales Court of Appeal has ruled that AI-created inventions are not patentable, but that may not be the end of the story

30 September 2021

Apple threat to leave British market over FRAND royalty is not credible, says judge

Latest decision in the iPhone maker’s long-running dispute with Optis makes clear that there is no reason to believe the company will pull-out of the UK rather than accept a court mandated licensing rate

28 September 2021

Private practice leadership roundtable

Featured in Special Report 2021 Q3: IP leadership - what it is and why it matters

09 September 2021

Life science leaders

Featured in Special Report 2021 Q3: IP leadership - what it is and why it matters

09 September 2021

Alibaba deploys tool to provide price guidance for patents going under the hammer

Intangio, developed by valuation specialists Inngot and IP services firm Rouse, is helping insolvency practitioners set a data-driven reserve price for patent assets at bankruptcy auctions

31 August 2021

IAM parent company acquires market-leading US patent litigation data and analytics firm

Austin-based Docket Navigator - which also covers trademarks, antitrust and other legal practice areas - becomes a Law Business Research company

25 August 2021

Chinese court enforces trade secret arbitration award of over $100 million against Chinese company

Dow and Johnson Matthey welcome enforcement action, which comes on the heels of a civil trade secrets litigation win in a different Chinese court last year

12 August 2021

Pfizer gets boost in landmark $1 billion pregabalin patent damages dispute

UK court sides with the drug company on key counterfactual assumptions in high-stakes compensation battle with the NHS and generics

03 August 2021

UK to look at whether change to the current SEP framework is required

Moved confirmed in press release issued by the country’s IP office last week with process scheduled to begin in the autumn

03 August 2021

English courts will thrive in life sciences patent litigation alongside the UPC

Rather than being overshadowed by the new pan-EU system, the UK will remain a crucial venue for pharma and biotech disputes

24 July 2021

Unlock unlimited access to all IAM content